Centene price target raised to $72 from $60 at BofA

BofA raised the firm’s price target on Centene (CNC) to $72 from $60 and keeps a Buy rating on the shares. The firm is “bullish” on and Molina Healthcare (MOH) on a view that Medicaid margins are likely bottoming in 2026 and a return to target margins are “more a matter of time and math, as state data slowly catches up to trend/risk pool shifts,” the analyst tells investors. The firm’s raised Centene target reflects early data points that trend and exchanges are tracking better than expected, the analyst tells investors.